These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 16799639

  • 1. Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation.
    Salatino M, Beguelin W, Peters MG, Carnevale R, Proietti CJ, Galigniana MD, Vedoy CG, Schillaci R, Charreau EH, Sogayar MC, Elizalde PV.
    Oncogene; 2006 Dec 14; 25(59):7723-39. PubMed ID: 16799639
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M, Schillaci R, Proietti CJ, Carnevale R, Frahm I, Molinolo AA, Iribarren A, Charreau EH, Elizalde PV.
    Oncogene; 2004 Jul 01; 23(30):5161-74. PubMed ID: 15122317
    [Abstract] [Full Text] [Related]

  • 3. Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas.
    Balañá ME, Lupu R, Labriola L, Charreau EH, Elizalde PV.
    Oncogene; 1999 Nov 04; 18(46):6370-9. PubMed ID: 10597237
    [Abstract] [Full Text] [Related]

  • 4. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA, Oza BP, Colomer R, Lupu R.
    Int J Oncol; 2005 Jun 04; 26(6):1507-15. PubMed ID: 15870863
    [Abstract] [Full Text] [Related]

  • 5. Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells.
    Proietti C, Salatino M, Rosemblit C, Carnevale R, Pecci A, Kornblihtt AR, Molinolo AA, Frahm I, Charreau EH, Schillaci R, Elizalde PV.
    Mol Cell Biol; 2005 Jun 04; 25(12):4826-40. PubMed ID: 15923602
    [Abstract] [Full Text] [Related]

  • 6. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
    Lanari C, Lüthy I, Lamb CA, Fabris V, Pagano E, Helguero LA, Sanjuan N, Merani S, Molinolo AA.
    Cancer Res; 2001 Jan 01; 61(1):293-302. PubMed ID: 11196177
    [Abstract] [Full Text] [Related]

  • 7. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer.
    Palmieri D, Halverson DO, Ouatas T, Horak CE, Salerno M, Johnson J, Figg WD, Hollingshead M, Hursting S, Berrigan D, Steinberg SM, Merino MJ, Steeg PS.
    J Natl Cancer Inst; 2005 May 04; 97(9):632-42. PubMed ID: 15870434
    [Abstract] [Full Text] [Related]

  • 8. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
    Liang Y, Wu J, Stancel GM, Hyder SM.
    J Steroid Biochem Mol Biol; 2005 Feb 04; 93(2-5):173-82. PubMed ID: 15860260
    [Abstract] [Full Text] [Related]

  • 9. Mechanisms involved in the evolution of progestin resistance in human breast cancer cells.
    Murphy LC, Dotzlaw H, Wong MS, Miller T, Murphy LJ.
    Cancer Res; 1991 Apr 15; 51(8):2051-7. PubMed ID: 1849041
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.
    Giulianelli S, Vaqué JP, Soldati R, Wargon V, Vanzulli SI, Martins R, Zeitlin E, Molinolo AA, Helguero LA, Lamb CA, Gutkind JS, Lanari C.
    Cancer Res; 2012 May 01; 72(9):2416-27. PubMed ID: 22396492
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways.
    Rivas MA, Carnevale RP, Proietti CJ, Rosemblit C, Beguelin W, Salatino M, Charreau EH, Frahm I, Sapia S, Brouckaert P, Elizalde PV, Schillaci R.
    Exp Cell Res; 2008 Feb 01; 314(3):509-29. PubMed ID: 18061162
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
    Benakanakere I, Besch-Williford C, Schnell J, Brandt S, Ellersieck MR, Molinolo A, Hyder SM.
    Clin Cancer Res; 2006 Jul 01; 12(13):4062-71. PubMed ID: 16818706
    [Abstract] [Full Text] [Related]

  • 17. Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate.
    Buchanan G, Birrell SN, Peters AA, Bianco-Miotto T, Ramsay K, Cops EJ, Yang M, Harris JM, Simila HA, Moore NL, Bentel JM, Ricciardelli C, Horsfall DJ, Butler LM, Tilley WD.
    Cancer Res; 2005 Sep 15; 65(18):8487-96. PubMed ID: 16166329
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The role and mechanism of progesterone receptor activation of extra-nuclear signaling pathways in regulating gene transcription and cell cycle progression.
    Boonyaratanakornkit V, Bi Y, Rudd M, Edwards DP.
    Steroids; 2008 Oct 15; 73(9-10):922-8. PubMed ID: 18321550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.